Jeffrey J. Popma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jeffrey J. Popma has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alexandra J. Lansky
1 shared publicationE. Magnus Ohman
1 shared publicationJeffrey Weitz
1 shared publicationJohn A. Bittl
1 shared publicationLansky
1 shared publicationPrpic
1 shared publication
Latest Publications
- 1 September 1999
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 14 (5) , 412-8
Clinical trials in interventional cardiology
Several well-designed, randomized trials and registries have recently been completed in patients undergoing percutaneous coronary intervention (PCI) for the treatment of symptomatic coronary artery disease. These studies have further clarified the value of newer pharmacologic and mechanical approaches to patients with atherosclerotic disease and have resulted in improved clinical outcomes in patients undergoing PCI. As a result, many of the older paradigms of lesion-specific device selection have been revised to include the intricate balance of devices and drugs, tailored to the specific clinical presentation and lesion morphology in patients undergoing PCI. This article reviews several recent clinical trials and discusses their impact on early and late outcomes in patients undergoing PCI for symptomatic coronary artery disease.
- 1 September 1999
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 14 (5) , 412-8
Clinical trials in interventional cardiology
Several well-designed, randomized trials and registries have recently been completed in patients undergoing percutaneous coronary intervention (PCI) for the treatment of symptomatic coronary artery disease. These studies have further clarified the value of newer pharmacologic and mechanical approaches to patients with atherosclerotic disease and have resulted in improved clinical outcomes in patients undergoing PCI. As a result, many of the older paradigms of lesion-specific device selection have been revised to include the intricate balance of devices and drugs, tailored to the specific clinical presentation and lesion morphology in patients undergoing PCI. This article reviews several recent clinical trials and discusses their impact on early and late outcomes in patients undergoing PCI for symptomatic coronary artery disease.
- 1 December 1998
- p. 22D-29D
Coronary Revascularization in Patients with Acute Coronary Syndromes.
Non-Q wave myocardial infarction and unstable angina remain major causes of morbidity and mortality in patients with atherosclerotic coronary artery disease. Judicious use of cardiac catheterization and coronary revascularization may further improve the prognosis of patients with these acute coronary syndromes (ACS). Patients with ACS at high risk for further cardiac events include those patients with electrocardiographic ST-segment depression, left bundle branch block, and, to a lesser extent, T-wave inversion, and those patients with recurrent pain, cardiac enzyme elevation, or exercise-induced ischemia after hospitalization. While these patient subgroups may benefit from early cardiac catheterization and revascularization, the role of routine coronary revascularization is less well established. Whereas one study has demonstrated reduced recurrent hospitalizations in patients treated with routine invasiveive strategy, another has suggested that outcomes are not different with the two approaches. Pending the results of a third ongoing study Ñ the Thrombolysis in Myocardial Infarction (TIMI)-18 trial Ñ a judicious approach to revascularization in patients presenting with ACS is warranted.
- 1 December 1998
- p. 22D-29D
Coronary Revascularization in Patients with Acute Coronary Syndromes.
Non-Q wave myocardial infarction and unstable angina remain major causes of morbidity and mortality in patients with atherosclerotic coronary artery disease. Judicious use of cardiac catheterization and coronary revascularization may further improve the prognosis of patients with these acute coronary syndromes (ACS). Patients with ACS at high risk for further cardiac events include those patients with electrocardiographic ST-segment depression, left bundle branch block, and, to a lesser extent, T-wave inversion, and those patients with recurrent pain, cardiac enzyme elevation, or exercise-induced ischemia after hospitalization. While these patient subgroups may benefit from early cardiac catheterization and revascularization, the role of routine coronary revascularization is less well established. Whereas one study has demonstrated reduced recurrent hospitalizations in patients treated with routine invasiveive strategy, another has suggested that outcomes are not different with the two approaches. Pending the results of a third ongoing study Ñ the Thrombolysis in Myocardial Infarction (TIMI)-18 trial Ñ a judicious approach to revascularization in patients presenting with ACS is warranted.